Lindsey Korbel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lindsey Korbel has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alvaro Coronado
Department of Pediatrics, St. Barnabas Hospital, 4432 3rd avenue, Bronx, NY 10457, USA
1 shared publication Joseph Kitzmiller
The Ohio State University College of Medicine, Columbus, OH, USA
1 shared publication- Joseph Paul Kitzmiller
Department of Biological Chemistry & Pharmacology, Ohio State University, Columbus, OH43210, USA
1 shared publication Mathew George
St Barnabas Hospital, Bronx, NY, USA
1 shared publication- Mathew George
Department of Pediatrics, SUNY Downstate Medical Center and Kings County Hospital Center, Brooklyn, NY 11203, USA
1 shared publication - Maya Haasz
Department of Pediatrics, St. Barnabas Hospital, 4432 3rd avenue, Bronx, NY 10457, USA
1 shared publication
Latest Publications
- 6 May 2014
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 53 (9) , 831-838
Clinically Relevant Pharmacogenomic Testing in Pediatric Practice
Clinicians and patients continue to convey interest in personalized medicine. The objective of personalized medicine is to improve healthcare by tailoring disease prevention, diagnosis, and treatment strategies for individuals based on their unique clinical history and genetic composition. This article offers an overview of pharmacogenomics, discusses caveats specific to pharmacogenomics in pediatric populations, provides evidence-based recommendations for pediatric clinicians, and offers insight regarding the future role of pharmacogenomics testing in pediatric medicine. Reviews of the current literature and thoughtful discussions are presented regarding the pharmacogenomics of antidepressants, codeine and oncologic, asthma, and immunomodulatory pharmacotherapies.
- 6 May 2014
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 53 (9) , 831-838
Clinically Relevant Pharmacogenomic Testing in Pediatric Practice
Clinicians and patients continue to convey interest in personalized medicine. The objective of personalized medicine is to improve healthcare by tailoring disease prevention, diagnosis, and treatment strategies for individuals based on their unique clinical history and genetic composition. This article offers an overview of pharmacogenomics, discusses caveats specific to pharmacogenomics in pediatric populations, provides evidence-based recommendations for pediatric clinicians, and offers insight regarding the future role of pharmacogenomics testing in pediatric medicine. Reviews of the current literature and thoughtful discussions are presented regarding the pharmacogenomics of antidepressants, codeine and oncologic, asthma, and immunomodulatory pharmacotherapies.
- Open Access
- 16 November 2013
- Published by Springer Nature in BMC Pediatrics
- Vol. 13 (1) , 187
Acute dyskinesia, myoclonus, and akathisa in an adolescent male abusing quetiapine via nasal insufflation: a case study
Although the benefits of antipsychotic pharmacotherapy can be pronounced, many patients develop unwanted adverse effects including a variety of movement disorders. Compared with the traditional antipsychotics, the atypical antipsychotics have a decreased risk for associated movement disorders. Drug-induced movement disorders can occur, however, and the risk of adverse events can increase significantly when medications are abused.
- 16 November 2013
- Published by Springer Nature in BMC Pediatrics
- Vol. 13 (1) , 187
Open AccessAcute dyskinesia, myoclonus, and akathisa in an adolescent male abusing quetiapine via nasal insufflation: a case study
Although the benefits of antipsychotic pharmacotherapy can be pronounced, many patients develop unwanted adverse effects including a variety of movement disorders. Compared with the traditional antipsychotics, the atypical antipsychotics have a decreased risk for associated movement disorders. Drug-induced movement disorders can occur, however, and the risk of adverse events can increase significantly when medications are abused.